[J01GA01, streptomycin, The risk or severity of neuromuscular blockade can be increased when Streptomycin is combined with Clindamycin.]
[M03AB01, succinylcholine, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Succinylcholine.]
[M04AB02, sulfinpyrazone, The metabolism of Clindamycin can be increased when combined with Sulfinpyrazone.]
[N05AL01, sulpiride, Sulpiride may increase the neurotoxic activities of Clindamycin.]
[L01BB02, mercaptopurine, The metabolism of Mercaptopurine can be decreased when combined with Clindamycin.]
[L02BA01, tamoxifen, The metabolism of Clindamycin can be increased when combined with Tamoxifen.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Clindamycin.]
[G03BA03, testosterone, The metabolism of Clindamycin can be increased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Tetracaine.]
[S03AA02, tetracycline, The risk or severity of neuromuscular blockade can be increased when Tetracycline is combined with Clindamycin.]
[N05AE05, lurasidone, Clindamycin may increase the neurotoxic activities of Lurasidone.]
[N04BC07, apomorphine, The metabolism of Clindamycin can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The metabolism of Clindamycin can be increased when combined with Thalidomide.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Clindamycin.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Clindamycin.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the neurotoxic activities of Clindamycin.]
[N05CA19, thiopental, The metabolism of Clindamycin can be increased when combined with Thiopental.]
[N05AB08, thioproperazine, Clindamycin may increase the neurotoxic activities of Thioproperazine.]
[N05AC02, thioridazine, Thioridazine may increase the neurotoxic activities of Clindamycin.]
[N05AF04, thiothixene, Clindamycin may increase the neurotoxic activities of Thiothixene.]
[N05AL03, tiapride, Clindamycin may increase the neurotoxic activities of Tiapride.]
[S01AA12, tobramycin, The risk or severity of neuromuscular blockade can be increased when Tobramycin is combined with Clindamycin.]
[N06AX05, trazodone, The metabolism of Clindamycin can be decreased when combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Clindamycin can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, Clindamycin may decrease the excretion rate of Triamcinolone which could result in a higher serum level.]
[N05CD05, triazolam, The serum concentration of Triazolam can be increased when it is combined with Clindamycin.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the neurotoxic activities of Clindamycin.]
[N05AD02, trifluperidol, Clindamycin may increase the neurotoxic activities of Trifluperidol.]
[N05AA05, triflupromazine, Triflupromazine may increase the neurotoxic activities of Clindamycin.]
[R03BA07, mometasone, The metabolism of Clindamycin can be increased when combined with Mometasone.]
[R06AD01, trimeprazine, Clindamycin may increase the neurotoxic activities of Alimemazine.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Clindamycin is combined with Trimethaphan.]
[N06AA06, trimipramine, Trimipramine may increase the neurotoxic activities of Clindamycin.]
[J01FA08, troleandomycin, The metabolism of Clindamycin can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Tubocurarine.]
[A10BH05, linagliptin, The metabolism of Clindamycin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Clindamycin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Telaprevir can be increased when it is combined with Clindamycin.]
[S01AA28, vancomycin, The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Clindamycin.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Clindamycin.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Clindamycin.]
[C08DA01, verapamil, The metabolism of Clindamycin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Clindamycin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Clindamycin can be increased when combined with Vinblastine.]
[C04AX07, vincamine, The serum concentration of Vincamine can be increased when it is combined with Clindamycin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Clindamycin.]
[L01CA03, vindesine, The serum concentration of Vindesine can be increased when it is combined with Clindamycin.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Clindamycin.]
[N05AF05, zuclopenthixol, Clindamycin may increase the neurotoxic activities of Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Clindamycin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Clindamycin can be increased when combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Clindamycin can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Clindamycin can be decreased when combined with Zafirlukast.]
[N05AE04, ziprasidone, The metabolism of Clindamycin can be decreased when combined with Ziprasidone.]
[J02AC03, voriconazole, The metabolism of Clindamycin can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Atracurium.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Clindamycin.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Clindamycin.]
[H02AB11, prednylidene, The serum concentration of Prednylidene can be increased when it is combined with Clindamycin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Clindamycin.]
[V03AX03, cobicistat, The metabolism of Clindamycin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Clindamycin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The metabolism of Clindamycin can be increased when combined with Enzalutamide.]
[A02AA05, magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium silicate.]
[H02AA01, aldosterone, The serum concentration of Aldosterone can be increased when it is combined with Clindamycin.]
[N05CA04, barbital, The metabolism of Clindamycin can be increased when combined with Barbital.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be increased when it is combined with Clindamycin.]
[J05AE04, nelfinavir, The metabolism of Clindamycin can be decreased when combined with Nelfinavir.]
[C08CA13, lercanidipine, The metabolism of Clindamycin can be decreased when combined with Lercanidipine.]
[N03AX22, perampanel, The metabolism of Clindamycin can be increased when combined with Perampanel.]
[N01AA01, ethyl ether, Clindamycin may increase the neurotoxic activities of Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Clindamycin can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Clindamycin.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Clindamycin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Clindamycin can be increased when combined with Glycerol phenylbutyrate.]
[N05AD07, benperidol, Clindamycin may increase the neurotoxic activities of Benperidol.]
[A12CC09, magnesium orotate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium orotate.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Benzocaine.]
[A12CC05, magnesium aspartate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium aspartate.]
[L01EC02, dabrafenib, The metabolism of Clindamycin can be increased when combined with Dabrafenib.]
[L01EE01, trametinib, The metabolism of Clindamycin can be increased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Benzyl alcohol.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Clindamycin.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Clindamycin.]
[N03AF04, eslicarbazepine, The metabolism of Clindamycin can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Clindamycin can be decreased when combined with Simeprevir.]
[A16AA07, metreleptin, The metabolism of Clindamycin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Clindamycin can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Clindamycin can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Clindamycin can be increased when combined with Betamethasone.]
[L04AC11, siltuximab, The metabolism of Clindamycin can be increased when combined with Siltuximab.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Clindamycin.]
[L01EM01, idelalisib, The metabolism of Clindamycin can be decreased when combined with Idelalisib.]
[J01XA05, oritavancin, The metabolism of Clindamycin can be increased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Dihydrostreptomycin.]
[N05AA04, acepromazine, Clindamycin may increase the neurotoxic activities of Acepromazine.]
[S03AA06, gentamicin, The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Clindamycin.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Clindamycin.]
[B01AA01, dicumarol, The serum concentration of Dicoumarol can be increased when it is combined with Clindamycin.]
[L04AC10, secukinumab, The metabolism of Clindamycin can be increased when combined with Secukinumab.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Clindamycin.]
[N02BE01, acetaminophen, The metabolism of Clindamycin can be increased when combined with Acetaminophen.]
[B01AA11, tioclomarol, The serum concentration of Tioclomarol can be increased when it is combined with Clindamycin.]
[J05AP06, asunaprevir, The metabolism of Clindamycin can be increased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, Clindamycin may increase the neurotoxic activities of Brexpiprazole.]
[N05AX15, cariprazine, Clindamycin may increase the neurotoxic activities of Cariprazine.]
[N05AB07, acetophenazine, Acetophenazine may increase the neurotoxic activities of Clindamycin.]
[A02BC03, lansoprazole, The metabolism of Clindamycin can be increased when combined with Lansoprazole.]
[J02AC05, isavuconazole, The metabolism of Clindamycin can be increased when combined with Isavuconazole.]
[M04AB05, lesinurad, The metabolism of Clindamycin can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Clindamycin.]
[N05CA05, aprobarbital, The metabolism of Clindamycin can be increased when combined with Aprobarbital.]
[L01XX52, venetoclax, The metabolism of Clindamycin can be decreased when combined with Venetoclax.]
[N04BC01, bromocriptine, The serum concentration of Bromocriptine can be increased when it is combined with Clindamycin.]
[A02AD05, aluminum magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium Aluminum Silicate.]
[N06AA19, amineptin, Clindamycin may increase the neurotoxic activities of Amineptine.]
[N05AX17, pimavanserin, Clindamycin may increase the neurotoxic activities of Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Clindamycin can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Clindamycin.]
[P01BE02, artemether, The metabolism of Clindamycin can be increased when combined with Artemether.]
[R06AX09, azatadine, The metabolism of Clindamycin can be increased when combined with Azatadine.]
[S01GX07, azelastine, The metabolism of Clindamycin can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Clindamycin can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Clindamycin can be decreased when combined with Ribociclib.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Clindamycin.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Clindamycin.]
[N06BC01, caffeine, The metabolism of Caffeine can be decreased when combined with Clindamycin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Clindamycin can be increased when combined with Calcitriol.]
[J05AE09, tipranavir, The metabolism of Clindamycin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Clindamycin.]
[L04AB02, infliximab, The metabolism of Clindamycin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Clindamycin can be increased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Clindamycin can be increased when combined with Brigatinib.]
[L04AC14, sarilumab, The metabolism of Clindamycin can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Clindamycin can be increased when combined with Delafloxacin.]
[L01XX59, enasidenib, The metabolism of Clindamycin can be increased when combined with Enasidenib.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Clindamycin.]
[A02BX12, bismuth subnitrate, Clindamycin may increase the neurotoxic activities of Bismuth subnitrate.]
[J05AG03, efavirenz, The metabolism of Clindamycin can be increased when combined with Efavirenz.]
[N05AD06, bromperidol, Clindamycin may increase the neurotoxic activities of Bromperidol.]
[R03BA02, budesonide, The metabolism of Clindamycin can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Clindamycin can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Clindamycin can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, Clindamycin may increase the neurotoxic activities of Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Clindamycin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Capsaicin.]
[L02BB05, apalutamide, The metabolism of Clindamycin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Clindamycin.]
[N03AX24, cannabidiol, The metabolism of Clindamycin can be decreased when combined with Cannabidiol.]
[J01GB14, plazomicin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Plazomicin.]
[H01CC03, elagolix, The metabolism of Clindamycin can be increased when combined with Elagolix.]
[L01XX62, ivosidenib, The metabolism of Clindamycin can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Clindamycin can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Clindamycin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Chloroprocaine.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Clindamycin.]
[L01ED05, lorlatinib, The metabolism of Clindamycin can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Clindamycin can be increased when combined with Emapalumab.]
[B01AC23, cilostazol, The metabolism of Clindamycin can be decreased when combined with Cilostazol.]
[N06AX27, esketamine, The metabolism of Clindamycin can be increased when combined with Esketamine.]
[J01FA09, clarithromycin, The metabolism of Clindamycin can be decreased when combined with Clarithromycin.]
[N05BA09, clobazam, The metabolism of Clindamycin can be increased when combined with Clobazam.]
[J01AA11, clomocycline, The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Clindamycin.]
[H02AB14, cloprednol, The serum concentration of Cloprednol can be increased when it is combined with Clindamycin.]
[L04AB01, etanercept, The metabolism of Clindamycin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The serum concentration of Cortivazol can be increased when it is combined with Clindamycin.]
[L01EM03, alpelisib, The metabolism of Clindamycin can be increased when combined with Alpelisib.]
[N05AA06, cyamemazine, Clindamycin may increase the neurotoxic activities of Cyamemazine.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the neurotoxic activities of Clindamycin.]
[N07XX11, pitolisant, The serum concentration of Clindamycin can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Clindamycin.]
[J01DB09, cephradine, The metabolism of Clindamycin can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Clindamycin.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Clindamycin.]
[N03AX25, cenobamate, The serum concentration of Clindamycin can be decreased when it is combined with Cenobamate.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Clindamycin.]
[J05AB16, remdesivir, The metabolism of Clindamycin can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Clindamycin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Clindamycin can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Clindamycin can be decreased when combined with Dutasteride.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Clindamycin.]
[N02CC06, eletriptan, The metabolism of Clindamycin can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Clindamycin can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Clindamycin can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Clindamycin can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Clindamycin.]
[S03AA08, chloramphenicol, The metabolism of Clindamycin can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Clindamycin can be decreased when combined with Tucatinib.]
[D07XB03, fluprednidene, The metabolism of Clindamycin can be increased when combined with Fluprednidene.]
[L01EX22, selpercatinib, The metabolism of Clindamycin can be decreased when combined with Selpercatinib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Dyclonine.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Clindamycin.]
[L04AC19, satralizumab, The serum concentration of Clindamycin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Clindamycin.]
[L01EX23, pralsetinib, The metabolism of Clindamycin can be increased when combined with Pralsetinib.]
[D01AE07, chlorphenesin, The metabolism of Clindamycin can be increased when combined with Chlorphenesin.]
[R06AB04, chlorpheniramine, The metabolism of Clindamycin can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the neurotoxic activities of Clindamycin.]
[N05AF03, chlorprothixene, Clindamycin may increase the neurotoxic activities of Chlorprothixene.]
[B06AC06, berotralstat, The metabolism of Clindamycin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Clindamycin can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Clindamycin.]
[L01FX21, naxitamab, Clindamycin may increase the neurotoxic activities of Naxitamab.]
[P03AX07, abametapir, The serum concentration of Clindamycin can be increased when it is combined with Abametapir.]
[N03AX10, felbamate, The metabolism of Clindamycin can be increased when combined with Felbamate.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Clindamycin.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Clindamycin.]
[R03BA03, flunisolide, The metabolism of Clindamycin can be increased when combined with Flunisolide.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Clindamycin.]
[A02BA01, cimetidine, The metabolism of Clindamycin can be decreased when combined with Cimetidine.]
[L01XX73, sotorasib, The serum concentration of Clindamycin can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Clindamycin can be decreased when combined with Ciprofloxacin.]
[P01CA03, fexinidazole, The metabolism of Clindamycin can be decreased when combined with Fexinidazole.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Clindamycin.]
[S01AA13, fusidic acid, The metabolism of Clindamycin can be decreased when combined with Fusidic acid.]
[S02BA08, fluocinolone acetonide, The metabolism of Clindamycin can be increased when combined with Fluocinolone acetonide.]
[N06AX25, St. John's wort extract, The metabolism of Clindamycin can be increased when combined with St. John's Wort.]
[J04BA01, clofazimine, The metabolism of Clindamycin can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Clindamycin can be increased when combined with Clofibrate.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clindamycin may increase the neurotoxic activities of Clomipramine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Clindamycin.]
[C01EB24, mavacamten, The serum concentration of Clindamycin can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Clindamycin.]
[N05AH06, clothiapine, Clindamycin may increase the neurotoxic activities of Clothiapine.]
[A04AA01, ondansetron, The metabolism of Clindamycin can be decreased when combined with Ondansetron.]
[G01AF02, clotrimazole, The metabolism of Clindamycin can be increased when combined with Clotrimazole.]
[N05AH02, clozapine, The metabolism of Clindamycin can be increased when combined with Clozapine.]
[J01GB12, arbekacin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Arbekacin.]
[H01AC08, somatrogon, The metabolism of Clindamycin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Clindamycin can be increased when combined with Bimekizumab.]
[J01XB01, colistin, The risk or severity of neuromuscular blockade can be increased when Colistin is combined with Clindamycin.]
[A10BX03, nateglinide, The metabolism of Clindamycin can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Clindamycin can be decreased when combined with Telithromycin.]
[H01AX01, pegvisomant, The metabolism of Clindamycin can be increased when combined with Pegvisomant.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Clindamycin.]
[J02AC02, itraconazole, The metabolism of Clindamycin can be decreased when combined with Itraconazole.]
[L01EA01, imatinib, The metabolism of Clindamycin can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Clindamycin can be decreased when combined with Posaconazole.]
[S01BA03, cortisone, The serum concentration of Cortisone can be increased when it is combined with Clindamycin.]
[A06AD01, magnesium carbonate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium carbonate.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium phosphate.]
[H02AB15, meprednisone, The serum concentration of Meprednisone can be increased when it is combined with Clindamycin.]
[C03DA04, eplerenone, The metabolism of Clindamycin can be decreased when combined with Eplerenone.]
[N05AD03, metylperon, Clindamycin may increase the neurotoxic activities of Melperone.]
[L01AA01, cyclophosphamide, The metabolism of Clindamycin can be increased when combined with Cyclophosphamide.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Clindamycin.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Clindamycin.]
[N06BA07, modafinil, The metabolism of Clindamycin can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Clindamycin can be decreased when combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Clindamycin can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The metabolism of Clindamycin can be decreased when combined with Vardenafil.]
[G03XA01, danazol, The metabolism of Clindamycin can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Dantrolene.]
[J04BA02, dapsone, The metabolism of Clindamycin can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Clindamycin can be increased when combined with Daunorubicin.]
[G03XX01, prasterone, The metabolism of Clindamycin can be decreased when combined with Prasterone.]
[J01AA01, demeclocycline, The risk or severity of neuromuscular blockade can be increased when Demeclocycline is combined with Clindamycin.]
[N06AX06, nefazodone, The metabolism of Clindamycin can be decreased when combined with Nefazodone.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Clindamycin.]
[M03AC11, cisatracurium, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Cisatracurium.]
[N06AA01, desipramine, Desipramine may increase the neurotoxic activities of Clindamycin.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be increased when it is combined with Clindamycin.]
[S01BA11, desonide, The metabolism of Clindamycin can be increased when combined with Desonide.]
[N03AF02, oxcarbazepine, The metabolism of Clindamycin can be increased when combined with Oxcarbazepine.]
[G01AF17, oxiconazole, The metabolism of Clindamycin can be increased when combined with Oxiconazole.]
[S03BA01, dexamethasone, The metabolism of Clindamycin can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Clindamycin can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Clindamycin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Clindamycin can be decreased when combined with Gefitinib.]
[R05DA09, dextromethorphan, The metabolism of Clindamycin can be decreased when combined with Dextromethorphan.]
[N06AB05, paroxetine, The metabolism of Clindamycin can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clindamycin can be decreased when combined with Clopidogrel.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Clindamycin.]
[N05BA01, diazepam, The metabolism of Clindamycin can be decreased when combined with Diazepam.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Phenol.]
[N06AA08, dibenzepin, Clindamycin may increase the neurotoxic activities of Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Cinchocaine.]
[J01CF01, dicloxacillin, The metabolism of Clindamycin can be increased when combined with Dicloxacillin.]
[J05AF02, didanosine, Didanosine may increase the neurotoxic activities of Clindamycin.]
[N05AD05, pipamperone, Clindamycin may increase the neurotoxic activities of Pipamperone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Clindamycin.]
[C08CA03, isradipine, The metabolism of Clindamycin can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Clindamycin can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Clindamycin.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Clindamycin.]
[C04AE04, dihydroergocristine, The serum concentration of Dihydroergocristine can be increased when it is combined with Clindamycin.]
[N02CA01, dihydroergotamine, The serum concentration of Dihydroergotamine can be increased when it is combined with Clindamycin.]
[J05AE08, atazanavir, The metabolism of Clindamycin can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Pramocaine.]
[D07AC18, prednicarbate, The metabolism of Clindamycin can be increased when combined with Prednicarbate.]
[C08DB01, diltiazem, The metabolism of Clindamycin can be decreased when combined with Diltiazem.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Clindamycin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Proparacaine.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Clindamycin.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Diphenhydramine.]
[N06AA23, quinupramine, Clindamycin may increase the neurotoxic activities of Quinupramine.]
[A03FA02, cisapride, The serum concentration of Cisapride can be increased when it is combined with Clindamycin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Clindamycin.]
[N05AL04, remoxipride, Remoxipride may increase the neurotoxic activities of Clindamycin.]
[C01BA03, disopyramide, Clindamycin may increase the QTc-prolonging activities of Disopyramide.]
[P03AA04, disulfiram, The metabolism of Clindamycin can be decreased when combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Clindamycin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Clindamycin can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The metabolism of Clindamycin can be increased when combined with Rifaximin.]
[N05AX08, risperidone, The metabolism of Clindamycin can be decreased when combined with Risperidone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Clindamycin.]
[A04AD12, aprepitant, The metabolism of Clindamycin can be decreased when combined with Aprepitant.]
[G04BE08, tadalafil, The metabolism of Clindamycin can be decreased when combined with Tadalafil.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Clindamycin.]
[C01EB18, ranolazine, The metabolism of Clindamycin can be decreased when combined with Ranolazine.]
[R03AC12, salmeterol, The metabolism of Clindamycin can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Clindamycin can be decreased when combined with Domperidone.]
[N06AA16, dothiepin, Clindamycin may increase the neurotoxic activities of Dosulepin.]
[N06AA12, doxepin, Doxepin may increase the neurotoxic activities of Clindamycin.]
[J01AA02, doxycycline, The risk or severity of neuromuscular blockade can be increased when Doxycycline is combined with Clindamycin.]
[N05AD08, droperidol, Droperidol may increase the neurotoxic activities of Clindamycin.]
[C10AA01, simvastatin, The metabolism of Clindamycin can be decreased when combined with Simvastatin.]
[N05AL02, sultopride, Clindamycin may increase the neurotoxic activities of Sultopride.]
[H01AA01, corticotropin, The metabolism of Clindamycin can be increased when combined with Corticotropin.]
[D01BA02, terbinafine, The metabolism of Clindamycin can be increased when combined with Terbinafine.]
[N05AB05, thiopropazate, Clindamycin may increase the neurotoxic activities of Thiopropazate.]
[N06AX14, tianeptine, Clindamycin may increase the neurotoxic activities of Tianeptine.]
[N03AX11, topiramate, The metabolism of Clindamycin can be increased when combined with Topiramate.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Clindamycin.]
[H02CA01, trilostane, The serum concentration of Trilostane can be increased when it is combined with Clindamycin.]
[N05AL06, veralipride, Clindamycin may increase the neurotoxic activities of Veralipride.]
[L01CA04, vinorelbine, The serum concentration of Vinorelbine can be increased when it is combined with Clindamycin.]
[C08CA12, mepirodipine, The metabolism of Clindamycin can be decreased when combined with Barnidipine.]
[N03AX15, zonisamide, The metabolism of Clindamycin can be decreased when combined with Zonisamide.]
[N05AX11, zotepine, Clindamycin may increase the neurotoxic activities of Zotepine.]
[C01BG01, moricizine, Moricizine may increase the neurotoxic activities of Clindamycin.]
[G02AB03, ergonovine, The serum concentration of Ergometrine can be increased when it is combined with Clindamycin.]
[C04AE01, ergoloid mesylates, USP, The serum concentration of Ergoloid mesylate can be increased when it is combined with Clindamycin.]
[N02CA02, ergotamine, The metabolism of Clindamycin can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The therapeutic efficacy of Erythromycin can be decreased when used in combination with Clindamycin.]
[N05CD04, estazolam, The serum concentration of Estazolam can be increased when it is combined with Clindamycin.]
[G03CA03, estradiol, The metabolism of Clindamycin can be decreased when combined with Estradiol.]
[R03BA09, fluticasone furoate, The metabolism of Clindamycin can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Clindamycin can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Clindamycin can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Clindamycin can be decreased when combined with Ethinylestradiol.]
[N03AB01, ethotoin, The metabolism of Clindamycin can be increased when combined with Ethotoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Clindamycin can be increased when combined with Etoposide.]
[N05AE03, sertindole, Clindamycin may increase the neurotoxic activities of Sertindole.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Clindamycin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Clindamycin.]
[R06AX12, terfenadine, The metabolism of Clindamycin can be increased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Clindamycin can be decreased when combined with Fluvoxamine.]
[C08CA02, felodipine, The metabolism of Clindamycin can be decreased when combined with Felodipine.]
[J01CF05, floxacillin, The metabolism of Clindamycin can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Clindamycin can be decreased when combined with Fluconazole.]
[H02AA02, fludrocortisone, The serum concentration of Fludrocortisone can be increased when it is combined with Clindamycin.]
[D07AC08, fluocinonide, The metabolism of Clindamycin can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Clindamycin may increase the neurotoxic activities of Melitracen.]
[H02AB03, fluocortolone, The metabolism of Clindamycin can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Clindamycin can be increased when combined with Ethanol.]
[N05AF01, flupenthixol, Flupentixol may increase the neurotoxic activities of Clindamycin.]
[N05AB02, fluphenazine, Fluphenazine may increase the neurotoxic activities of Clindamycin.]
[N05AG01, fluspirilene, Clindamycin may increase the neurotoxic activities of Fluspirilene.]
[L02BB01, flutamide, The metabolism of Clindamycin can be decreased when combined with Flutamide.]
[S01AA07, framycetin, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Clindamycin.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Clindamycin.]
[M03AA01, alcuronium, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Alcuronium.]
[J05AE10, darunavir, The metabolism of Clindamycin can be decreased when combined with Darunavir.]
[N05AL05, amisulpride, Clindamycin may increase the neurotoxic activities of Amisulpride.]
[M03AC02, gallamine, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Gallamine.]
[N03AA04, barbexaclone, The metabolism of Clindamycin can be increased when combined with Barbexaclone.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Clindamycin.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Clindamycin.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Clindamycin.]
[J05AG04, etravirine, The metabolism of Clindamycin can be increased when combined with Etravirine.]
[N01AH02, alfentanil, The serum concentration of Alfentanil can be increased when it is combined with Clindamycin.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Clindamycin.]
[A10BB01, glyburide, The metabolism of Clindamycin can be decreased when combined with Glyburide.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Clindamycin.]
[B01AA12, fluindione, The serum concentration of Fluindione can be increased when it is combined with Clindamycin.]
[D01BA01, griseofulvin, The metabolism of Clindamycin can be increased when combined with Griseofulvin.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Clindamycin.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Clindamycin.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Clindamycin.]
[L01CE02, irinotecan, The metabolism of Clindamycin can be decreased when combined with Irinotecan.]
[B05CB03, magnesium citrate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium citrate.]
[A12CC03, magnesium gluconate, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium gluconate.]
[J05AG01, nevirapine, The metabolism of Clindamycin can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Clindamycin can be decreased when combined with Nilvadipine.]
[S02BA01, hydrocortisone, The metabolism of Clindamycin can be increased when combined with Hydrocortisone.]
[D07AC16, hydrocortisone aceponate, The metabolism of Clindamycin can be increased when combined with Hydrocortisone aceponate.]
[D07AB11, hydrocortisone probutate, The metabolism of Clindamycin can be increased when combined with Hydrocortisone probutate.]
[N05AX07, prothipendyl, Clindamycin may increase the neurotoxic activities of Prothipendyl.]
[N05BB01, hydroxyzine, The metabolism of Clindamycin can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Clindamycin can be increased when combined with Rifabutin.]
[B05CB02, sodium citrate, Clindamycin may increase the neurotoxic activities of Sodium citrate.]
[L01AA06, ifosfamide, The metabolism of Clindamycin can be increased when combined with Ifosfamide.]
[N06AA02, imipramine, Imipramine may increase the neurotoxic activities of Clindamycin.]
[L01CD01, paclitaxel, The metabolism of Clindamycin can be increased when combined with Paclitaxel.]
[N06AX17, milnacipran, The metabolism of Clindamycin can be decreased when combined with Milnacipran.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Clindamycin is combined with Cyclopentamine.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Articaine.]
[N05BA12, alprazolam, The serum concentration of Alprazolam can be increased when it is combined with Clindamycin.]
[C10AA06, cerivastatin, The metabolism of Clindamycin can be increased when combined with Cerivastatin.]
[J05AF04, stavudine, Stavudine may increase the neurotoxic activities of Clindamycin.]
[N06AA13, iprindole, Clindamycin may increase the neurotoxic activities of Iprindole.]
[N05AA07, chlorproethazine, Clindamycin may increase the neurotoxic activities of Chlorproethazine.]
[J04AC01, isoniazid, The metabolism of Clindamycin can be decreased when combined with Isoniazid.]
[S01AA24, kanamycin, The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Clindamycin.]
[A07BC02, kaolin, Kaolin can cause a decrease in the absorption of Clindamycin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Clindamycin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Clindamycin can be increased when combined with Ketamine.]
[J02AB02, ketoconazole, The metabolism of Clindamycin can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Clindamycin can be decreased when combined with Levoketoconazole.]
[V03AC03, deferasirox, The metabolism of Clindamycin can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Clindamycin can be increased when combined with Abatacept.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Clindamycin.]
[C03CC01, ethacrynic acid, The risk or severity of neuromuscular blockade can be increased when Etacrynic acid is combined with Clindamycin.]
[G03AD01, levonorgestrel, The metabolism of Clindamycin can be decreased when combined with Levonorgestrel.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Lidocaine.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Lincomycin.]
[N06BA13, armodafinil, The metabolism of Clindamycin can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The serum concentration of Lisuride can be increased when it is combined with Clindamycin.]
[N06AA07, lofepramine, Clindamycin may increase the neurotoxic activities of Lofepramine.]
[C10AA02, lovastatin, The metabolism of Clindamycin can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, Loxapine may increase the neurotoxic activities of Clindamycin.]
[J01AA04, lymecycline, The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Clindamycin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Clindamycin.]
[B05XA11, magnesium chloride, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium chloride.]
[G04BX01, magnesium hydroxide, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium oxide.]
[V04CC02, magnesium sulfate, The risk or severity of neuromuscular blockade can be increased when Magnesium sulfate is combined with Clindamycin.]
[L01EA03, nilotinib, The metabolism of Clindamycin can be decreased when combined with Nilotinib.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Clindamycin is combined with Mecamylamine.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Clindamycin.]
[N03AA01, mephobarbital, The metabolism of Clindamycin can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The metabolism of Clindamycin can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, Mesoridazine may increase the neurotoxic activities of Clindamycin.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Clindamycin.]
[J01AA05, methacycline, The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Clindamycin.]
[N07BC02, methadone, The metabolism of Clindamycin can be decreased when combined with Methadone.]
[G02CB05, metergoline, The serum concentration of Metergoline can be increased when it is combined with Clindamycin.]
[H03BB02, methimazole, The metabolism of Clindamycin can be decreased when combined with Methimazole.]
[N05AA02, methotrimeprazine, Clindamycin may increase the neurotoxic activities of Methotrimeprazine.]
[V04CG05, methylene blue, The metabolism of Clindamycin can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The serum concentration of Methylergometrine can be increased when it is combined with Clindamycin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Clindamycin.]
[H02AB04, methylprednisolone, The metabolism of Clindamycin can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Clindamycin can be increased when combined with Rufinamide.]
[N02CA04, methysergide, The serum concentration of Methysergide can be increased when it is combined with Clindamycin.]
[P01AB01, metronidazole, The metabolism of Clindamycin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Clindamycin can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Clindamycin can be decreased when combined with Miconazole.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Clindamycin.]
[G03XB01, mifepristone, The metabolism of Clindamycin can be increased when combined with Mifepristone.]
[J01AA08, minocycline, The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Clindamycin.]
[L01XX23, mitotane, The metabolism of Clindamycin can be increased when combined with Mitotane.]
[N05AE02, molindone, Clindamycin may increase the neurotoxic activities of Molindone.]
[C01BD01, amiodarone, The metabolism of Clindamycin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Clindamycin can be decreased when combined with Amitriptyline.]
[L04AB05, certolizumab pegol, The metabolism of Clindamycin can be increased when combined with Certolizumab pegol.]
[M03AC03, vecuronium, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Vecuronium.]
[N05CA02, amobarbital, The metabolism of Clindamycin can be increased when combined with Amobarbital.]
[N06AA17, amoxapine, Amoxapine may increase the neurotoxic activities of Clindamycin.]
[N03AB05, fosphenytoin, The metabolism of Clindamycin can be increased when combined with Fosphenytoin.]
[J01CF06, nafcillin, The metabolism of Clindamycin can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Clindamycin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Clindamycin can be increased when combined with Anakinra.]
[A10BG01, troglitazone, The metabolism of Clindamycin can be increased when combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Clindamycin.]
[S03AA01, neomycin, The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Clindamycin.]
[A10BX02, repaglinide, The serum concentration of Repaglinide can be increased when it is combined with Clindamycin.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Clindamycin.]
[S01AA23, netilmicin, The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Clindamycin.]
[N06AX23, desvenlafaxine, The metabolism of Clindamycin can be decreased when combined with Desvenlafaxine.]
[C08CA04, nicardipine, The metabolism of Clindamycin can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The serum concentration of Nicergoline can be increased when it is combined with Clindamycin.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Clindamycin is combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Clindamycin can be increased when combined with Nifedipine.]
[C08CA07, nisoldipine, The metabolism of Clindamycin can be decreased when combined with Nisoldipine.]
[C08CA08, nitrendipine, The metabolism of Clindamycin can be decreased when combined with Nitrendipine.]
[N05CF03, zaleplon, The metabolism of Clindamycin can be decreased when combined with Zaleplon.]
[G03DC02, norethindrone, The metabolism of Clindamycin can be decreased when combined with Norethisterone.]
[C02KX01, bosentan, The metabolism of Clindamycin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the neurotoxic activities of Clindamycin.]
[L04AC04, rilonacept, The metabolism of Clindamycin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Clindamycin can be increased when combined with Omeprazole.]
[N06AA05, opipramol, Clindamycin may increase the neurotoxic activities of Opipramol.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Clindamycin.]
[N02AA05, oxycodone, The metabolism of Clindamycin can be decreased when combined with Oxycodone.]
[N05AE01, oxypertine, Clindamycin may increase the neurotoxic activities of Oxypertine.]
[S01AA04, oxytetracycline, The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Clindamycin.]
[N05AH05, asenapine, Clindamycin may increase the neurotoxic activities of Asenapine.]
[M03AC01, pancuronium, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Pancuronium.]
[J04AB30, capreomycin, The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Clindamycin.]
[H02AB05, paramethasone, The serum concentration of Paramethasone can be increased when it is combined with Clindamycin.]
[A07AA06, paromomycin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Paromomycin.]
[N05AG03, penfluridol, Clindamycin may increase the neurotoxic activities of Penfluridol.]
[N05CA01, pentobarbital, The metabolism of Clindamycin can be increased when combined with Pentobarbital.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be decreased when combined with Clindamycin.]
[N05AB10, perazine, Clindamycin may increase the neurotoxic activities of Perazine.]
[N04BC02, pergolide, The serum concentration of Pergolide can be increased when it is combined with Clindamycin.]
[N05AB03, perphenazine, Perphenazine may increase the neurotoxic activities of Clindamycin.]
[B01AA02, phenindione, The serum concentration of Phenindione can be increased when it is combined with Clindamycin.]
[N03AA02, phenobarbital, The metabolism of Clindamycin can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The serum concentration of Phenprocoumon can be increased when it is combined with Clindamycin.]
[M02AA01, phenylbutazone, The metabolism of Clindamycin can be increased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Clindamycin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Clindamycin can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Clindamycin can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Clindamycin.]
[C10AA05, atorvastatin, The risk or severity of adverse effects can be increased when Clindamycin is combined with Atorvastatin.]
[J01CA12, piperacillin, The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Clindamycin.]
[J05AE01, saquinavir, The metabolism of Clindamycin can be decreased when combined with Saquinavir.]
[N05AC04, pipothiazine, Clindamycin may increase the neurotoxic activities of Pipotiazine.]
[J05AG02, delavirdine, The metabolism of Clindamycin can be decreased when combined with Delavirdine.]
[L04AC08, canakinumab, The metabolism of Clindamycin can be increased when combined with Canakinumab.]
[S03AA03, polymyxin B, Clindamycin may increase the neurotoxic activities of Polymyxin B.]
[J05AE03, ritonavir, The metabolism of Clindamycin can be decreased when combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Clindamycin.]
[P02BA01, praziquantel, The metabolism of Clindamycin can be decreased when combined with Praziquantel.]
[S03BA02, prednisolone, The metabolism of Clindamycin can be increased when combined with Prednisolone.]
[H02AB07, prednisone, The serum concentration of Prednisone can be increased when it is combined with Clindamycin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Clindamycin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Clindamycin can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Clindamycin can be increased when combined with Probenecid.]
[C01BA02, procainamide, The risk or severity of neuromuscular blockade can be increased when Procainamide is combined with Clindamycin.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Procaine.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the neurotoxic activities of Clindamycin.]
[G03DA04, progesterone, The metabolism of Clindamycin can be increased when combined with Progesterone.]
[N05AA03, promazine, Promazine may increase the neurotoxic activities of Clindamycin.]
[R06AD02, promethazine, Promethazine may increase the neurotoxic activities of Clindamycin.]
[N05AC01, periciazine, Clindamycin may increase the neurotoxic activities of Periciazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Clindamycin.]
[C07AA05, propranolol, The metabolism of Clindamycin can be decreased when combined with Propranolol.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Clindamycin.]
[N06AA11, protriptyline, Protriptyline may increase the neurotoxic activities of Clindamycin.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Clindamycin.]
[P02CC01, pyrantel, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Pyrantel.]
[P01AX05, quinacrine, The metabolism of Clindamycin can be decreased when combined with Quinacrine.]
[C01BA01, quinidine, The metabolism of Clindamycin can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Clindamycin can be increased when combined with Quinine.]
[C02AA02, reserpine, The metabolism of Clindamycin can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Clindamycin can be increased when combined with Rifampicin.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Rolitetracycline.]
[N05CA06, secobarbital, The metabolism of Clindamycin can be increased when combined with Secobarbital.]
[J01GB08, sisomicin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Sisomicin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Clindamycin.]
[D07AB02, hydrocortisone butyrate, The metabolism of Clindamycin can be increased when combined with Hydrocortisone butyrate.]
[A05AA02, ursodiol, The metabolism of Clindamycin can be increased when combined with Ursodeoxycholic acid.]
